scholarly article | Q13442814 |
P50 | author | Justin Kale | Q47155592 |
David William Andrews | Q37838821 | ||
P2093 | author name string | Brian Leber | |
Aisha Shamas-Din | |||
P2860 | cites work | Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist | Q40088689 |
Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex | Q40237169 | ||
Bcl-2 changes conformation to inhibit Bax oligomerization | Q40287064 | ||
A role for proapoptotic BID in the DNA-damage response | Q40381562 | ||
The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. | Q40485961 | ||
During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria | Q40554731 | ||
The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL. | Q40749844 | ||
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms | Q40976477 | ||
Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins | Q41092707 | ||
Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. | Q41509622 | ||
Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis | Q41822569 | ||
BH3-triggered structural reorganization drives the activation of proapoptotic BAX. | Q41884328 | ||
Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process | Q41975085 | ||
Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers | Q42156839 | ||
Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding | Q42803499 | ||
Molecular details of Bax activation, oligomerization, and membrane insertion. | Q42910802 | ||
Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices | Q43235008 | ||
Membrane promotes tBID interaction with BCL(XL). | Q45815145 | ||
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. | Q46142204 | ||
Proapoptotic BID is an ATM effector in the DNA-damage response | Q46669145 | ||
Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes | Q46847162 | ||
Non-apoptotic role of BID in inflammation and innate immunity | Q50521157 | ||
Assembly of Bcl-2 into microsomal and outer mitochondrial membranes | Q72331978 | ||
Cardiolipin provides specificity for targeting of tBid to mitochondria | Q73062575 | ||
Nonionic detergents induce dimerization among members of the Bcl-2 family | Q73343305 | ||
Helix 6 of tBid is necessary but not sufficient for mitochondrial binding activity | Q73436542 | ||
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies | Q79370601 | ||
Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators | Q81043167 | ||
Structure assembly of Bcl-x(L) through alpha5-alpha5 and alpha6-alpha6 interhelix interactions in lipid membranes | Q84569267 | ||
The Bax carboxy-terminal hydrophobic helix does not determine organelle-specific targeting but is essential for maintaining Bax in an inactive state and for stable mitochondrial membrane insertion | Q84654319 | ||
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC | Q22009974 | ||
PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 | ||
Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis | Q24291662 | ||
Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers | Q24292693 | ||
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function | Q24293924 | ||
The Molecular Mechanism of Noxa-induced Mitochondrial Dysfunction in p53-Mediated Cell Death | Q24294863 | ||
Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis | Q24296781 | ||
Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol | Q24298758 | ||
Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization | Q24300125 | ||
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins | Q24302494 | ||
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis | Q24306444 | ||
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors | Q24310559 | ||
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 | ||
BID: a novel BH3 domain-only death agonist | Q24320091 | ||
Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands | Q24321449 | ||
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax | Q24323186 | ||
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members | Q24337108 | ||
Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel | Q24523479 | ||
harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L) | Q24532147 | ||
Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 | ||
Post-transcriptional and post-translational regulation of Bcl2. | Q37813761 | ||
BH3-only proteins: Orchestrators of apoptosis | Q37819153 | ||
Autophagy and cancer | Q37967998 | ||
Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. | Q38268983 | ||
A unified model of mammalian BCL-2 protein family interactions at the mitochondria. | Q39292731 | ||
Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells | Q39371756 | ||
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival | Q39761203 | ||
Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim. | Q39905589 | ||
Conformation of the Bax C-terminus regulates subcellular location and cell death | Q24534099 | ||
Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival | Q24635383 | ||
Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis | Q24669892 | ||
An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway | Q24670136 | ||
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis | Q24670370 | ||
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity | Q24675444 | ||
Movement of Bax from the Cytosol to Mitochondria during Apoptosis | Q24677881 | ||
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity | Q24683846 | ||
A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast | Q24685400 | ||
Solution structure of BID, an intracellular amplifier of apoptotic signaling | Q27617719 | ||
Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists | Q27617723 | ||
Structure of Bax: coregulation of dimer formation and intracellular localization | Q27628839 | ||
The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site | Q27640443 | ||
The structure of a Bcl-xL/Bim fragment complex: implications for Bim function | Q27642185 | ||
Structural insights into the degradation of Mcl-1 induced by BH3 domains | Q27644256 | ||
BAX activation is initiated at a novel interaction site | Q27652635 | ||
Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands | Q27657282 | ||
Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes | Q27658925 | ||
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer | Q27662487 | ||
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death | Q27733156 | ||
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis | Q27734734 | ||
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis | Q28144256 | ||
BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria | Q28205892 | ||
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death | Q28242641 | ||
BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity | Q28249553 | ||
Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K | Q28299861 | ||
Induction of apoptosis by the Bcl-2 homologue Bak | Q28299871 | ||
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak | Q28299882 | ||
Barrel-stave model or toroidal model? A case study on melittin pores. | Q28346167 | ||
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death | Q28363890 | ||
Role of Bax and Bak in mitochondrial morphogenesis | Q28591724 | ||
MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria | Q28594262 | ||
Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets | Q28910218 | ||
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line | Q29399117 | ||
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane | Q29616354 | ||
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly | Q29617135 | ||
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics | Q29620467 | ||
Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores. | Q30157467 | ||
Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss | Q30476336 | ||
Bcl-XL inhibits membrane permeabilization by competing with Bax. | Q33343021 | ||
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis | Q33854131 | ||
Bax forms an oligomer via separate, yet interdependent, surfaces | Q33885192 | ||
BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions | Q34078104 | ||
Regulation of Bcl-xL: a little bit of this and a little bit of STAT. | Q34086142 | ||
The Soluble Form of Bax Regulates Mitochondrial Fusion via MFN2 Homotypic Complexes | Q34160226 | ||
Multiple Functions of BCL-2 Family Proteins | Q34326024 | ||
Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? | Q34621961 | ||
Measuring and Modeling Apoptosis in Single Cells | Q34921455 | ||
Bcl-2-family proteins and the role of mitochondria in apoptosis | Q35595911 | ||
Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. | Q35687120 | ||
Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. | Q35880175 | ||
A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. | Q35917067 | ||
BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins | Q36118310 | ||
Autophagy and Neuronal Cell Death in Neurological Disorders | Q36329444 | ||
The permeability transition pore complex in cancer cell death | Q36558006 | ||
Role of the mitochondrial membrane permeability transition in cell death | Q36669154 | ||
Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes | Q36799170 | ||
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins | Q37068553 | ||
Regulation of Bcl-2 family proteins by posttranslational modifications. | Q37108448 | ||
Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation | Q37158414 | ||
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members | Q37237621 | ||
The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor | Q37308429 | ||
C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1. | Q37431712 | ||
The autophagy effector Beclin 1: a novel BH3-only protein | Q37566206 | ||
BAD: undertaker by night, candyman by day. | Q37566231 | ||
Noxa: at the tip of the balance between life and death. | Q37566236 | ||
Bid: a Bax-like BH3 protein. | Q37566240 | ||
Still embedded together binding to membranes regulates Bcl-2 protein interactions. | Q37773789 | ||
P433 | issue | 4 | |
P304 | page(s) | a008714 | |
P577 | publication date | 2013-04-01 | |
P1433 | published in | Cold Spring Harbor Perspectives in Biology | Q3927509 |
P1476 | title | Mechanisms of action of Bcl-2 family proteins | |
P478 | volume | 5 |
Q57496288 | -Butylhydroperoxide induces apoptosis in RAW264.7 macrophages a mitochondria-mediated signaling pathway |
Q60957183 | 23-Hydroxyursolic Acid Isolated from the Stem Bark of Induces Apoptosis through Fas/Caspase-8-Dependent Pathway in HL-60 Human Promyelocytic Leukemia Cells |
Q64898292 | A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells. |
Q58712247 | A structural investigation of NRZ mediated apoptosis regulation in zebrafish |
Q38877050 | Acetogenins from Annona muricata as potential inhibitors of antiapoptotic proteins: a molecular modeling study |
Q58596800 | Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells |
Q39593727 | An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway. |
Q37565012 | Angiotensin II protects cortical neurons against oxygen-glucose deprivation-induced injury in vitro |
Q35161655 | Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway |
Q28649832 | Apoptosis induced by Ginkgo biloba (EGb761) in melanoma cells is Mcl-1-dependent |
Q38869563 | Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner |
Q92503806 | Apoptotic cell-derived exosomes: messages from dying cells |
Q41827156 | Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling |
Q33361524 | Assembling the puzzle: Oligomerization of α-pore forming proteins in membranes |
Q28552226 | BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells |
Q47155532 | BCL-2 family proteins: changing partners in the dance towards death |
Q90287849 | BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction |
Q35251905 | BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells. |
Q59137520 | BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy |
Q60907777 | Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy |
Q38197005 | Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment |
Q36293251 | Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax. |
Q64101953 | Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2 |
Q34582485 | Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by inducing mitochondrial dysfunction |
Q37644143 | Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice. |
Q89782386 | C5, A Cassaine Diterpenoid Amine, Induces Apoptosis via the Extrinsic Pathways in Human Lung Cancer Cells and Human Lymphoma Cells |
Q38915465 | CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer |
Q38553692 | Caspases and Thrombin Activity Regulation by Specific Serpin Inhibitors in Bovine Skeletal Muscle. |
Q97531506 | Cell death in the gut epithelium and implications for chronic inflammation |
Q55009922 | Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis. |
Q92738232 | Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development |
Q91651575 | Citral Induced Apoptosis through Modulation of Key Genes Involved in Fatty Acid Biosynthesis in Human Prostate Cancer Cells: In Silico and In Vitro Study |
Q38767178 | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway. |
Q38941168 | Comparison of S-nitrosoglutathione- and staurosporine-induced apoptosis in human neural cells |
Q39077541 | Comparison of membrane insertion pathways of the apoptotic regulator Bcl-xL and the diphtheria toxin translocation domain |
Q33875537 | Conditionally and transiently disordered proteins: awakening cryptic disorder to regulate protein function |
Q50888233 | Conformational Heterogeneity in the Activation Mechanism of Bax. |
Q58737147 | Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax |
Q38172752 | Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. |
Q64110985 | Control of viral infections by epigenetic-targeted therapy |
Q59810003 | Critical role of tristetraprolin and AU-rich element RNA-binding protein 1 in the suppression of cancer cell growth by globular adiponectin |
Q92960276 | Crystal Structure of African Swine Fever Virus A179L with the Autophagy Regulator Beclin |
Q92376626 | Deoxypodophyllotoxin Exerts Anti-Cancer Effects on Colorectal Cancer Cells Through Induction of Apoptosis and Suppression of Tumorigenesis |
Q37164293 | Development of a lytic peptide derived from BH3-only proteins |
Q40217481 | Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
Q57476780 | Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation |
Q36337499 | Dissecting the in vivo leukemogenic potency of BCLxl |
Q37603694 | Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis |
Q42959533 | Effects of matrine on the proliferation of HT29 human colon cancer cells and its antitumor mechanism |
Q64109908 | Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism |
Q36089817 | Ethyl acetate extract of Hypericum japonicum induces apoptosis via the mitochondria-dependent pathway in vivo and in vitro |
Q53609777 | Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity. |
Q90799071 | Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins |
Q88122162 | Extracellular Vesicles Derived from Wharton's Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells |
Q41708811 | Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine |
Q33720383 | From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine. |
Q64971959 | Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer. |
Q92187370 | Gasdermins in Apoptosis: New players in an Old Game |
Q33582984 | Generation of homologous cell pairs using the oral lymphatic system |
Q27027460 | Getting TRAIL back on track for cancer therapy |
Q38943370 | Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA. |
Q34432852 | Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway |
Q52684466 | Grouper iridovirus GIV66 is a Bcl-2 protein that inhibits apoptosis by exclusively sequestering Bim. |
Q37709973 | Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities. |
Q92388210 | Gypenosides Prevent H2O2-Induced Retinal Ganglion Cell Apoptosis by Concurrently Suppressing the Neuronal Oxidative Stress and Inflammatory Response |
Q57065814 | HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection? |
Q89594685 | Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2 |
Q59355718 | Hepatitis B virus upregulates host microRNAs that target apoptosis-regulatory genes in an in vitro cell model |
Q93164719 | Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling |
Q58733788 | Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma |
Q42132814 | Identification of 7-(4'-Cyanophenyl)indoline-1-benzenesulfonamide as a mitotic inhibitor to induce apoptotic cell death and inhibit autophagy in human colorectal cancer cells |
Q64259674 | Immunomodulatory Effects of (24R)-Pseudo-Ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on Cyclophosphamide-Induced Immunosuppression and Their Anti-Tumor Effects Study |
Q52316132 | Indian Ginseng (Withania somnifera) supplementation ameliorates oxidative stress and mitochondrial dysfunctions in experimental model of stroke |
Q64929448 | Induction of neutrophil apoptosis by a Bcl-2 inhibitor reduces particulate matter-induced lung inflammation. |
Q90654712 | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
Q38846360 | Intersection of mitochondrial fission and fusion machinery with apoptotic pathways: Role of Mcl-1. |
Q36982290 | Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model |
Q90161935 | Involvement of Metabolic Lipid Mediators in the Regulation of Apoptosis |
Q42643167 | Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway. |
Q35460893 | Isolation and functional analysis of mitochondria from cultured cells and mouse tissue |
Q34806907 | IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention. |
Q57126620 | L. Improved Heart Function and Inhibited Myocardial Apoptosis in Isolated Rat Heart Following Ischemia-Reperfusion Injury |
Q90286167 | Lipoprotein Particle Formation by Proapoptotic tBid |
Q47309267 | Lysophosphatidic Acid Accelerates Development of Porcine Embryos by Activating Formation of the Blastocoel. |
Q36184998 | MCL-1 Depletion Impairs DNA Double-Strand Break Repair and Reinitiation of Stalled DNA Replication Forks. |
Q58694408 | MCL-1 inhibition in cancer treatment |
Q47148226 | MOMP, cell suicide as a BCL-2 family business |
Q51277574 | Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety: Synthesis, preliminary anticancer evaluation, and molecular modeling studies. |
Q38185804 | Many players in BCL-2 family affairs |
Q58760846 | Mechanism of Lakoochin A Inducing Apoptosis of A375.S2 Melanoma Cells through Mitochondrial ROS and MAPKs Pathway |
Q47123534 | Membrane insertion of the BAX core, but not latch domain, drives apoptotic pore formation |
Q88255415 | MiR-138/SIRT1 axis is implicated in impaired learning and memory abilities of cerebral ischemia/reperfusion injured rats |
Q37604587 | MicroRNA-135a Regulates Apoptosis Induced by Hydrogen Peroxide in Rat Cardiomyoblast Cells |
Q36935173 | Mimicking Cdk2 phosphorylation of Bcl-xL at Ser73 results in caspase activation and Bcl-xL cleavage |
Q28383717 | Minimalist Model Systems Reveal Similarities and Differences between Membrane Interaction Modes of MCL1 and BAK |
Q45969652 | Mitochondria, Bioenergetics and Apoptosis in Cancer. |
Q38760561 | Mitochondria-Judges and Executioners of Cell Death Sentences |
Q90266427 | Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing |
Q32186320 | Molecular Role of EGFR-MAPK Pathway in Patchouli Alcohol-Induced Apoptosis and Cell Cycle Arrest on A549 Cells In Vitro and In Vivo. |
Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
Q64882683 | Mouse ER+/PIK3CAH1047R breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents. |
Q42593963 | Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid |
Q40862731 | Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications |
Q101455784 | Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins |
Q35731554 | Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim. |
Q37257680 | Oncogenic Mutations Differentially Affect Bax Monomer, Dimer, and Oligomeric Pore Formation in the Membrane |
Q33841579 | Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs) |
Q38753745 | Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis |
Q38809317 | Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients. |
Q38262894 | Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin |
Q64904953 | Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance. |
Q94545391 | Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward |
Q92837933 | Protective effect of TSG against oxygen-glucose deprivation in cardiomyoblast cell line H9c2: involvement of Bcl-2 family, Caspase 3/9, and Akt signaling pathway |
Q34017896 | Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapy |
Q61805628 | Protosappanin B promotes apoptosis and causes G cell cycle arrest in human bladder cancer cells |
Q53080449 | Regulation of apoptosis by an intrinsically disordered region of Bcl-xL. |
Q33752784 | Release of Cytochrome C from Bax Pores at the Mitochondrial Membrane |
Q64948157 | Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action. |
Q26864167 | Restoration of mitochondria function as a target for cancer therapy |
Q35131426 | Rhizoma Dioscoreae extract protects against alveolar bone loss in ovariectomized rats via microRNAs regulation |
Q38239533 | Risk factors for intraocular involvement in patients with primary central nervous system lymphoma. |
Q37548069 | Role of Eukaryotic Initiation Factors during Cellular Stress and Cancer Progression |
Q33724132 | Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats |
Q54979506 | SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. |
Q99567219 | Salidroside downregulates microRNA‑133a and inhibits endothelial cell apoptosis induced by oxidized low‑density lipoprotein |
Q33684181 | Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway |
Q90439248 | Schmallenberg virus induces apoptosis in Vero cell line via extrinsic and intrinsic pathways in a time and dose dependent manner |
Q64259664 | Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies |
Q51760860 | Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy |
Q36066400 | Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy |
Q91341224 | Small-molecule allosteric inhibitors of BAX |
Q40764980 | Sphingosine-1-phosphate and its effect on glucose deprivation/glucose reload stress: from gene expression to neuronal survival |
Q40241754 | Structural basis of apoptosis inhibition by the fowlpox virus protein FPV039. |
Q37357054 | Structural biology of the Bcl-2 family and its mimicry by viral proteins |
Q51456092 | Substituted indole Mcl-1 inhibitors: a patent evaluation (WO2015148854A1). |
Q37836415 | Subversion of Cell-Autonomous Host Defense by Chlamydia Infection |
Q92617575 | TOM40 Targets Atg2 to Mitochondria-Associated ER Membranes for Phagophore Expansion |
Q101165825 | Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance |
Q39456786 | Targeting BCL-2-like Proteins to Kill Cancer Cells |
Q26853686 | Targeting BCL2-Proteins for the Treatment of Solid Tumours |
Q39267135 | Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment. |
Q37406677 | Tea polyphenols protect against ischemia/reperfusion-induced liver injury in mice through anti-oxidative and anti-apoptotic properties |
Q41922877 | The Bcl-2 Family in Host-Virus Interactions. |
Q92662243 | The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms |
Q38268329 | The Bcl-2 family: structures, interactions and targets for drug discovery |
Q48290361 | The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes. |
Q92239784 | The Calotropis Gigantea Methanolic Extract Induces Apoptosis in Human Breast Carcinoma Cells |
Q91983853 | The Latency-Associated Transcript Inhibits Apoptosis via Downregulation of Components of the Type I Interferon Pathway during Latent Herpes Simplex Virus 1 Ocular Infection |
Q42744055 | The apoptotic pore on mitochondria: are we breaking through or still stuck? |
Q92906324 | The carboxyl-terminal sequence of bim enables bax activation and killing of unprimed cells |
Q64074627 | The modulates the neurotoxicity induced by fipronil in male albino rats |
Q38331196 | The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. |
Q38848876 | The principle of conformational signaling |
Q34043792 | The role of death-associated protein 3 in apoptosis, anoikis and human cancer |
Q39028789 | The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function |
Q38715430 | Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies |
Q36243019 | Time depended Bcl-2 inhibition might be useful for a targeted drug therapy. |
Q35317287 | Transformations of the macromolecular landscape at mitochondria during DNA-damage-induced apoptotic cell death. |
Q46335242 | Treatment of allicin improves maturation of immature oocytes and subsequent developmental ability of preimplantation embryos |
Q37424051 | Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation |
Q40857877 | Tumor protein Tctp regulates axon development in the embryonic visual system |
Q90235444 | Ubiquitin-proteasome mediated cyclin C degradation promotes cell survival following nitrogen starvation |
Q57162415 | Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study |
Q38540071 | p53 in survival, death and metabolic health: a lifeguard with a licence to kill |
Q24294675 | tBid undergoes multiple conformational changes at the membrane required for Bax activation |
Search more.